Johannes Bloehdorn
11PUBLICATIONS
69CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jun 02, 2025
NOTCH1 signaling is dysregulated by loss of the deubiquitinase USP28 with del(11q), uncovering USP28 inhibition as novel therapeutic target in CLL.Alena Sophie Ehrmann, Miguel Quijada-Álamo, Viola Close
|Apr 06, 2023
Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia.Qu Jiang, Johanna Stachelscheid, Johannes Bloehdorn
|Oct 20, 2022
Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.Maurizio Mangolini, Alba Maiques-Diaz, Stella Charalampopoulou
|Sep 30, 2022
The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL.Johanna Stachelscheid, Qu Jiang, Christoph Aszyk
|May 06, 2022
The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia.Lisa Rusyn, Sebastian Reinartz, Anastasia Nikiforov
|Mar 26, 2022
Salvage Therapy for Alveolar Echinococcosis-A Case Series.Sanne Burkert, Lynn Peters, Johannes Bloehdorn
Pageof 2
Frequent Collaborators
2 joint publications
Johanna Stachelscheid
2 joint publications
Andrew Moore
2 joint publications
Christian Pallasch
2 joint publications
Catherine J Wu
2 joint publications
Ingo Ringshausen
1 joint publications
Jingyu Chen
1 joint publications
Daniel Mertens
1 joint publications
Antonella Santoro
1 joint publications
Joseph R Boyd
1 joint publications
Paul J Lehner
